Jump to any asset
As of September 9, 2026, Welltower Inc. (WELL) trades at $235.90. CleaRank Financial AI rates it Buy with a fair value of $260.50, 10.4% above the current price. Wall Street's consensus target is $260.50 across 22 analysts. RSI at 50 is in neutral territory, and the price is below its 50-day average of $237.47.
Welltower Inc. (WELL)
Welltower Inc. NYSE
$235.90
-1.350 (-0.57%)
At close: Sep 9, 4:00 PM EDT
AI Analyst Consensus
75 / 100
Welltower Inc. (WELL) is trading at $235.90, with a consensus rating of Buy and a median analyst target price of $260.50, implying a 10.4% upside. The company is experiencing strong revenue growth, with current quarter estimates at +39.00% year-over-year, reaching $3.7 billion. This growth is underpinned by significant insider buying totaling $5.4 million, indicating strong management conviction. The REIT's health is further supported by a positive dividend yield of 1.30% and a neutral RSI momentum. Welltower's operational performance has been solid, with recent earnings beats on EPS, including a 10% surprise in the latest quarter. While the P/E ratio of 107.52 is high relative to sector averages, the strong revenue growth and positive insider activity suggest this may be justified by future expansion potential. The company operates in the Healthcare Facilities REIT sector, which is generally stable, and its forward revenue estimates show continued positive momentum, with next year's growth projected at 16.00%.
WELL Price Analysis
Market Metrics
Open
$236.98
Day Range
$234.78 to $238.22
Prev Close
$237.25
Volume
1.80M
52-Week Range
$163.75 to $255.20
Market Cap
$169.98B
Peer Benchmarking
Valuation vs Sector (Real Estate)
Performance vs XLRE
Sector Position Analysis
Trading at a significant premium to sector peers (+322%), suggesting market expectations for superior growth or market position.
WELL Analysis
Company's Health
4/5
12-Month Analyst Target
+10.43% Upside
Median of 22 analysts (12-month)
$260.50
AI Technical Analysis
Welltower Inc. (WELL) is currently trading below its 50-day and 20-day moving averages at $237.47 and $237.63 respectively, suggesting near-term headwinds. However, the stock remains above its 200-day SMA of $211.30, indicating a longer-term bullish trend. The RSI is neutral at 50.31, showing no overbought or oversold conditions, while MACD is slightly positive at 0.61. The nearest support level is the current price, with the 200-day SMA at $211.30 acting as a key longer-term support. Resistance is observed around the 50-day SMA at $237.47 and the 20-day EMA at $237.63. Volume has been below average recently, with 1.8 million shares traded compared to a 2.69 million average, suggesting caution among traders.
ProTips
- Insider buying totaling $5.4 million by some insiders.'s (WELL) future prospects, making it a key factor to monitor.
- Welltower Inc. (WELL) is trading below its 50-day and 20-day moving averages, suggesting potential near-term weakness, while remaining above the 200-day SMA, indicating a longer-term bullish trend.
- Given the high P/E ratio, investors should closely watch Welltower Inc.'s (WELL) ability to sustain its impressive revenue growth and manage its balance sheet effectively to justify its current valuation.
Key Catalysts
Bullish
Significant Insider Buying Activity
Insiders, have purchased $5.4 million worth of Welltower Inc. (WELL) stock, indicating strong confidence in the company's future performance and growth prospects.
Source: Insider Trading FilingsBullish
Strong Revenue Growth Momentum
Welltower Inc. (WELL) is projected to achieve 39.00% revenue growth in the current quarter and 16.00% in the next year, driven by demand in the healthcare facilities sector.
Source: Wall Street EstimatesBullish
Positive Earnings Surprises
The company recently delivered a 10% EPS surprise, demonstrating its ability to exceed analyst expectations and potentially drive future stock performance.
Source: Earnings ReportsBearish
Elevated Valuation Metrics
Welltower Inc.'s (WELL) P/E ratio of 107.52 is significantly higher than sector averages, posing a risk if growth expectations are not met or if market sentiment shifts.
Source: Financial Data AnalysisNeutral
Mixed Stock Price Reaction to Earnings
Despite recent EPS beats, Welltower Inc. (WELL) has experienced varied stock price reactions, suggesting that market sentiment may not fully price in positive earnings news.
Source: Market DataMarket Outlook
The base case outlook for Welltower Inc. (WELL) is positive, with a median analyst target price of $260.50, suggesting a 10.4% upside from its current trading price. The company's strong revenue growth trajectory, projected at 39.00% for the current quarter and 16.00% for next year, combined with significant insider buying, indicates a favorable near to medium-term outlook. Potential upside catalysts include continued strong earnings performance and successful execution of its growth strategy within the healthcare facilities REIT sector. Conversely, a significant shift in interest rate policy or increased competition could pressure valuations. The company's ability to maintain its growth momentum and manage its debt levels will be critical factors in achieving its long-term potential, as highlighted by the $342.31 projected base case price by 2030.
Key Statistics
| Market Cap | 169.98B |
|---|---|
| P/E Ratio | 107.52 |
| EPS (TTM) | 2.22 |
| Dividend Yield | 1.30% |
| 52 Week High | 255.20 |
| 52 Week Low | 163.75 |
Welltower Inc. (WELL) presents a mixed valuation picture, with a P/E ratio of 107.52 significantly above the Real Estate sector average of 25.5. This premium valuation is somewhat justified by its exceptional revenue growth, projected at 39.1% year-over-year for the current quarter, far exceeding the sector average of 10.0%. The company's profitability, as indicated by its EPS of $2.22, needs to be viewed in the context of its growth trajectory. While the P/E ratio appears stretched, the substantial insider buying of $5.4 million signals strong confidence in the company's future prospects. The dividend yield of 1.30% offers a modest income stream. The company's balance sheet strength and ability to fund growth initiatives will be key factors to monitor, especially given the high valuation. Comparisons to peers like Ventas (VTR) and Medical Properties Trust (MPW) in the healthcare REIT space will be important for assessing relative value.
Earnings & Growth Analysis
Welltower Inc. (WELL) recently reported an EPS beat of $0.55 versus an estimate of $0.50 for the latest quarter, a 10% surprise, though the stock saw a 1% decline. Prior to that, the company missed estimates by 6.78% in the February quarter, with actual EPS of $0.55 against an estimate of $0.59, which was followed by a 3.51% price increase. The company demonstrated a significant earnings beat in December 2025, reporting $0.38 against an estimate of $0.18, a 111.11% surprise, which resulted in a 2.42% stock price decrease.
Key Risks
Welltower Inc. (WELL) faces valuation risk, with its P/E ratio significantly higher than sector averages, suggesting that future growth expectations are already priced in. Additionally, while recent earnings have shown positive surprises, the stock price reaction has been mixed, indicating potential investor skepticism about sustained profitability. Competitive pressures within the healthcare REIT sector could also impact Welltower's market position and pricing power.
Technical Indicators
| RSI (14) | 50.31 |
|---|---|
| MACD | 0.61 |
| SMA 50 | 237.47 |
| SMA 200 | 211.30 |
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($237.47) above the 200-day SMA ($211.30), price is trading below the 50-day SMA.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.16
Weak correlation
Nasdaq 100 (QQQ)
+0.06
Weak correlation
Bitcoin (BTC)
-0.01
Weak correlation
Gold (XAU)
+0.06
Weak correlation
Check Custom Correlation
Calculating correlation...
WELL Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
🟢 LONG ENTRY (click to switch)
CONSERVATIVE
$231.18
2% below current price (Pullback entry)
Lower risk, wait for pullback
AGGRESSIVE
$235.90
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$224.25
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (50.3) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$242.74
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$254.30
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$265.86
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for WELL is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 9, 2026.Growth of $10,000
A $10,000 investment in WELL in September 2016 would be worth about $32,169 today, compared with about $35,913 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in WELL today could grow to about $25,365 by 2036 in the base case, with a bull case near $92,978 and a bear case around $6,920. Projections are statistical simulations, not guarantees.
WELL Stock Price Prediction: 2030
CleaRank's simulation projects a price near $342 for WELL by 2030 in the base case, from $236 today (1.5x over 4 years). The downside path ends near $151. These are outcomes of a Monte Carlo simulation run on WELL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $172 | $259 | $390 |
| 2028 | $159 | $284 | $508 |
| 2029 | $153 | $312 | $635 |
| 2030 | $151 | $342 | $778 |
| 2031 | $150 | $376 | $941 |
| 2032 | $151 | $412 | $1,128 |
| 2033 | $153 | $453 | $1,342 |
| 2034 | $155 | $497 | $1,587 |
| 2035 | $159 | $545 | $1,870 |
| 2036 | $163 | $598 | $2,193 |
Method: 10,000 simulated price paths using WELL's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
WELL Insider Trading Analysis
Bought
$5.4M
2 Transactions
Sold
None
No open-market sells
Insiders
12
Active Traders
Avg Transaction
$2.7M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 14, 2019 | DEROSA THOMAS J
Chief Executive Officer
|
Sell | 19.3K | $1.5M |
| Feb 28, 2019 | KERR MERCEDES T
Officer
|
Sell | 5.0K | $372.5K |
| Dec 11, 2018 | KERR MERCEDES T
Officer
|
Sell | 4.3K | $317.7K |
| Dec 9, 2024 | BACON KENNETH J
Director
|
Sell | 2.2K | $286.4K |
| Jun 4, 2024 | BACON KENNETH J
Director
|
Sell | 1.8K | $187.0K |
| Mar 13, 2019 | GOODEY JOHN
Chief Financial Officer
|
Sell | 1 | $44 |
| Jun 6, 2018 | TRUMBULL RICHARD SCOTT
Director
|
Sell | 1 | $30 |
| Aug 26, 2026 | GUNDLACH ANDREW
Director
|
Buy | 10.0K | $2.4M |
| Aug 20, 2026 | LOPEZ DENNIS G
Director
|
Grant | 73 | $17.3K |
| Jun 26, 2026 | MITRA SHANKH
Chief Executive Officer
|
Grant | 3.9K | - |
Page 1 of 1
Frequently Asked Questions
What is Welltower Inc.'s consensus rating?
Welltower Inc. (WELL) currently holds a 'Buy' consensus rating from Wall Street analysts. This rating is supported by a consensus score of 75 out of 100, reflecting a generally positive outlook among analysts covering the stock.
What is Welltower Inc.'s price target?
The median analyst price target for Welltower Inc. (WELL) is $260.50, with a high of $292 and a low of $219. This implies an upside potential of 10.4% from the current stock price of $235.90.
Is Welltower Inc. stock a buy right now?
With a 'Buy' consensus rating and a median analyst target price of $260.50, Welltower Inc. (WELL) presents a potentially attractive opportunity. Strong revenue growth and significant insider buying further support a bullish stance, though its high P/E ratio warrants careful consideration.
What is Welltower Inc.'s long-term outlook?
The long-term outlook for Welltower Inc. (WELL) appears positive, with a projected base case price of $342.31 by 2030 based on Monte Carlo simulations. The company's strategy in healthcare facilities REITs, coupled with ongoing revenue growth, suggests sustained expansion potential over the next several years.
How has Welltower Inc. performed in recent earnings reports?
Welltower Inc. (WELL) recently reported a 10% EPS surprise in its latest quarter, beating estimates. While prior quarters showed mixed results with both beats and misses, the overall trend suggests operational resilience, though stock price reactions have varied.
What are the main risks facing Welltower Inc.?
The primary risks for Welltower Inc. (WELL) include its high P/E ratio, which suggests elevated valuation expectations, and mixed stock price reactions to recent earnings reports. Competitive pressures within the healthcare REIT sector also pose a potential challenge to its market position.
What is Welltower Inc.'s revenue growth rate?
Welltower Inc. (WELL) is experiencing strong revenue growth, with current quarter estimates showing a 39.00% year-over-year increase to $3.7 billion. Forward estimates indicate continued strong growth, with next year's revenue projected to increase by 16.00%.
What is Welltower Inc.'s projected stock price for 2030?
Based on Monte Carlo simulations, Welltower Inc. (WELL) has a projected base case stock price of $342.31 for 2030. The downside projection is $150.53 and the upside projection is $778.43. These figures represent simulation outcomes, not guaranteed price targets.